The Future of Value and Access: Global Lessons for Australian Medicines Policy

Discuss

Exchange

Network

Join healthcare leaders, policymakers and industry stakeholders for an exclusive forum with Professor Mark Sculpher, a globally recognised expert in health economics and health technology assessment (HTA).

As governments and health systems grapple with rising healthcare costs and increasing demand for innovation, the frameworks used to assess value, determine pricing and enable patient access are undergoing significant change.

Through two interactive discussion sessions, Professor Sculpher will explore:

• Global developments in medicines pricing policy, including Most Favoured Nation (MFN) pricing approaches, recent reforms in the United Kingdom, and emerging trends across Europe.
• Evolving approaches to defining and assessing value in healthcare, including the ISPOR Value Flower, the GRACE framework and the recommendations of the HEMA report.

Attendees will gain insights into the international trends shaping health technology assessment, reimbursement and access decisions, and discuss the implications for Australian medicines policy in the years ahead.

The forum will conclude with networking refreshments, providing an opportunity to connect with peers and continue the conversation.